gemfibrozil has been researched along with Hyperchylomicronemia Late Onset in 8 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Thirteen patients with phenotypic type V hyperlipidemia were treated with either gemfibrozil (Lopid) or a placebo in a randomized, double-blind, crossover study for two 8-week periods." | 2.66 | The hypolipidemic effects of gemfibrozil in type V hyperlipidemia. A double-blind, crossover study. ( Bacon, SP; Connor, WE; Illingworth, DR; Leaf, DA; Sexton, G, 1989) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (37.50) | 18.7374 |
| 1990's | 2 (25.00) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bloomfield, G | 1 |
| Dunbar, K | 1 |
| Tavella, M | 1 |
| Corder, CN | 1 |
| McConathy, W | 1 |
| Farnier, M | 1 |
| Athyros, VG | 1 |
| Papageorgiou, AA | 1 |
| Kontopoulos, AG | 1 |
| Mikhailidis, DP | 1 |
| Jagroon, IA | 1 |
| Leaf, DA | 1 |
| Connor, WE | 1 |
| Illingworth, DR | 1 |
| Bacon, SP | 1 |
| Sexton, G | 1 |
| Gotto, AM | 1 |
| Jones, PH | 1 |
| Scott, LW | 1 |
| Schaefer, EJ | 1 |
| Levy, RI | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Estudio clínico Fase III Para Evaluar la Eficacia terapéutica en Pacientes Mexicanos Con Dislipidemia Mediante el Uso vía Oral de L-Carnitina + Atorvastatina Comparado Con Atorvastatina[NCT03696940] | Phase 3 | 120 participants (Actual) | Interventional | 2018-05-28 | Active, not recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for gemfibrozil and Hyperchylomicronemia Late Onset
| Article | Year |
|---|---|
The diagnosis and management of hyperlipidemia.
Topics: Adolescent; Adult; Child; Child, Preschool; Cholesterol; Cholestyramine Resin; Chylomicrons; Clofibr | 1986 |
Pathogenesis and management of lipoprotein disorders.
Topics: Abetalipoproteinemia; Adolescent; Adult; Aged; Child; Child, Preschool; Cholestyramine Resin; Chylom | 1985 |
3 trials available for gemfibrozil and Hyperchylomicronemia Late Onset
| Article | Year |
|---|---|
Cerivastatin in the treatment of mixed hyperlipidemia: the RIGHT study. The Cerivastatin Study Group. Cerivastatin Gemfibrozil Hyperlipidemia Treatment.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cholesterol, HDL; Cholesterol, VLDL; Cholestyramine Resi | 1998 |
Statin-fibrate combinations in patients with combined hyperlipedemia.
Topics: Clofibric Acid; Coronary Disease; Drug Therapy, Combination; Fibric Acids; Follow-Up Studies; Gemfib | 2001 |
The hypolipidemic effects of gemfibrozil in type V hyperlipidemia. A double-blind, crossover study.
Topics: Adult; Aged; Body Weight; Cholesterol, VLDL; Clinical Protocols; Clinical Trials as Topic; Double-Bl | 1989 |
3 other studies available for gemfibrozil and Hyperchylomicronemia Late Onset
| Article | Year |
|---|---|
It's all connected.
Topics: Gemfibrozil; Humans; Hyperlipoproteinemia Type V; Hypolipidemic Agents; Male; Middle Aged; Retinal D | 2006 |
Effect of gemfibrozil on fatty acids in lipid fractions of plasma from patients with hypertriglyceridemia.
Topics: Fatty Acids; Fatty Acids, Unsaturated; Gemfibrozil; Humans; Hyperlipoproteinemia Type IV; Hyperlipop | 1993 |
Ciprofibrate versus gemfibrozil in the treatment of mixed hyperlipidemias: an open-label, multicenter study.
Topics: Clofibric Acid; Fibric Acids; Gemfibrozil; Humans; Hyperlipoproteinemia Type V; Hypolipidemic Agents | 2001 |